DOJ Finds UCSD Medical School Violated Title VI in Race-Conscious Admissions

The Department of Justice announced on July 20, 2026, that it had concluded its investigation into UC San Diego School of Medicine and found the school violated Title VI by discriminating against white and Asian American applicants in its admissions process. The DOJ’s finding follows similar conclusions at UCLA’s medical school earlier this year and ongoing investigations into Stanford and Ohio State. This is no longer a probe—it is a formal determination that the school’s holistic review process unlawfully considered race.

The administration is invoking the Supreme Court’s 2023 ruling in Students for Fair Admissions v. Harvard to argue that all race-conscious admissions—including those used by graduate and professional schools—are illegal under the Equal Protection Clause and Title VI. Civil rights legal experts contend this interpretation extends the Harvard decision beyond its holding, which explicitly addressed undergraduate admissions at two specific institutions. The practical consequence is severe: medical schools have long cited the compelling state interest in training physicians who are more likely to practice in rural and underserved communities—disproportionately Black and Hispanic doctors who help close health equity gaps. By finding violations at UCSD and UCLA, the DOJ is effectively dismantling the medical workforce pipeline that serves America’s most vulnerable patients, and chilling lawful diversity efforts nationwide.

The fight now moves to the courts and Congress. Affected schools can challenge the DOJ’s findings in federal court, arguing that narrowly tailored race-conscious admissions remain permissible under the Harvard framework. Advocates should push for legislative clarity that protects medical schools’ ability to consider race as one factor among many in admissions, consistent with the compelling state interest in public health equity.